Skip to ContentSkip to Navigation
About us Practical matters How to find us dr. O.W. Akkerman

Research interests

Pharmacokinetics and pharmacodynamics of anti TB drugs

Inhalation of antimicrobial drugs

Holistic approach of TB care

Publications

Availability of drugs and resistance testing for BPaLM regimen for rifampicin-resistant tuberculosis in Europe

Endobronchial tuberculosis

Imaging in pulmonary infections of immunocompetent adult patients

Measurement of isoniazid in tuberculosis patients using finger sweat with creatinine normalisation: A controlled administration study

Pancreatitis delays the absorption of first-line anti-TB drugs

Post-TB lung disease: keep going beyond TB!

Post-tuberculosis treatment paradoxical reactions

Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'

The agreement between bronchoalveolar lavage, bronchial wash and sputum culture: a retrospective study

Tuberculosis impacts multiple aspects in quality of life in a Romanian cohort of drug-susceptible and drug resistant patients: A patient-reported outcome measures study

Read more

Press/media

‘Belet met therapeutic drug monitoring resistentie tegen tbc-behandeling’

Tuberculosis: 'Real possibility' Wales will see sanatoriums return if disease not treated properly

Dr. Akkerman: ‘Met “slim” pillenpotje geef je tbc-patiënt vertrouwen en regie terug’

Slim pillenpotje stimuleert therapietrouw patiënten met tuberculose

RTL EditieNL: Corona

Focus (NTR): Massale reisgedrag en tuberculose

Read more